CIK 0001386570 · Large accelerated filer
Niagen Bioscience, Inc.
Sign in to watch- Ticker
- NAGE
- Exchange
- Nasdaq
- Industry
- Medicinal Chemicals & Botanical Products
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 262940963
- Phone
- 310-388-6706
- Business address
- 10900 WILSHIRE BLVD, SUITE 600, LOS ANGELES, CA, 90024
- Former names
- ChromaDex Corp., CODY RESOURCES, INC.
- 8-K Event Results of operations · Regulation FD disclosure
- 8-K Event Material agreement · New debt or obligation
- 10-Q Report Quarterly Report
- CT ORDER Other Confidential Order
- CT ORDER Other Confidential Order
- 8-K Event Other events
- EFFECT Other Notice of Effectiveness
- 424B3 Offering Prospectus
- CORRESP Other Correspondence Between Filers and SEC Staff
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-3/A Offering Registration Statement
- UPLOAD Other SEC-generated Letter
- S-3 Offering Registration Statement
- D Other Notice of Sales of Unregistered Securities
- 4 Insider Changes in Ownership
- SC 13D/A Stake Beneficial Ownership Report
- 8-K Event Material agreement · Unregistered share sale
- 8-K Event Material agreement
- 8-K Event Results of operations · Regulation FD disclosure
- 10-Q Report Quarterly Report
Page 17 of 50 · 981 filings